IL6 and breast cancer: Intrinsic production of IL-6 in the ER(+) breast cancer cell lines MCF-7, T47D, ZR-75-1, and SK-BR promotes cell death in response to drugs, inducing morphological changes, and apoptosis with DNA fragmentation [37-39].